Catey Hill helps MarketWatch readers find retirement destinations that fit their specific wish lists. Most are looking for cheaper places to live. But now a reader with a net worth of $5 million wants someplace that isn’t stiflingly hot, has good health care and isn’t in California. She offered three suggestions, and hundreds of readers added their own recommendations. What’s yours?
Here are more MarketWatch articles for good weekend reading about finances, investing and retirement.
Tesla does it again
surprised analysts with strong third-quarter earnings and cash flow, as its operating margins improved. But something similar happened a year ago, when it seemed Tesla had turned the corner. Then subsequent quarters were less rosy. Will history repeat? Here’s a sampling of opinion:
• Tim Mullaney: Tesla’s road gets easier from here
• Tae Kim at Barron’s: Don’t trust Tesla stock’s big move — here’s why
• Vitaly Katsenelson: Tesla’s future might not be in Elon Musk’s hands
A Nobel approach to selecting biotech stocks
Stocks in the biotechnology space are notoriously volatile — the results of drug trials can make or break companies, especially small ones. So Michael Brush looks to James Allison, a cancer-therapy researcher who was awarded the Nobel Prize, for long-term investments in the sector.
Facts won’t win an argument
Why does someone continue to argue, even when you are absolutely sure of your facts? Eleanor Gordon-Smith suggests a different approach that involves understanding where the other person is coming from.
Here’s where a successful hedge-fund manager thinks you should invest
Silvia Ascarelli interviews Larry Hite, a money manager with an excellent performance record who is very excited about one particular area of the stock market.
Open enrollment season is almost here — consider doing this
If your employer provides health insurance, making this change can save you money now while giving you an opportunity to invest more for retirement.
Schwab may drive another revolution for investors
is a pioneer in lowering commissions for investors, including its recent move to eliminate most online commissions. Now the company is eyeing another pioneering move: allowing investors to buy fractional shares of stock, which could be a game changer for the ETF and mutual-fund industries.
Growth has been a winner, but maybe value’s time has come
Growth-stock strategies have crushed value-oriented strategies over the past 12 years. Now Mark Hulbert has data indicating it may be time to switch to value.
An emergency estate plan